Data availability
Enquiries about data availability should be directed to the authors.
References
Raghubeer S, Matsha TE (2021) Methylenetetrahydrofolate (MTHFR), the one-carbon cycle, and cardiovascular risks. Nutrients 13:4562
Lemarie CA et al (2011) Mthfr deficiency induces endothelial progenitor cell senescence via uncoupling of eNOS and downregulation of SIRT1. Am J Physiol Heart Circ Physiol 300:H745-753
Parmeggiani F et al (2019) Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration. Sci Rep 9:2614
Carrizzo A (2022) SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency. CMLS. https://doi.org/10.1007/s00018-022-04429-5
Bonnefont-Rousselot D (2016) Resveratrol and cardiovascular diseases. Nutrients 8:250
Santulli G et al (2014) A selective microRNA-based strategy inhibits restenosis while preserving endothelial function. J Clin Invest 124:4102–4114
Reagan A et al (2020) A common risk variant in the MTHFR gene contributes to age-related cerebrovascular dysfunction in VCID. Alzheimer’s Dementia 16:e038657
Li Y et al (2020) Association between MTHFR C677T/A1298C and susceptibility to autism spectrum disorders: a meta-analysis. BMC Pediatr 20:449
Carafa V, Nebbioso A, Altucci L (2012) Sirtuins and disease: the road ahead. Front Pharmacol 3:4
Yang Q et al (2012) Prospective study of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of all-cause and cardiovascular disease mortality among 6000 US adults. Am J Clin Nutr 95:1245–1253
Cappuccio G et al (2014) Pearls & oy-sters: familial epileptic encephalopathy due to methylenetetrahydrofolate reductase deficiency. Neurology 83:e41-44
Wan L et al (2018) Methylenetetrahydrofolate reductase and psychiatric diseases. Transl Psychiatry 8:242
Funding
The Santulli’s Lab is supported in part by the National Institutes of Health (NIH): National Heart, Lung, and Blood Institute (NHLBI: R01HL164772, R01-HL159062, R01-HL146691, T32-HL144456), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK: R01-DK123259, R01-DK033823) to G.S., by the Diabetes Action Research and Education Foundation (to G.S.), and by the Monique Weill-Caulier and Irma T. Hirschl Trusts (to G.S.). S.S.J. is supported by a postdoctoral fellowship of the American Heart Association (AHA-21POST836407).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jankauskas, S.S., Mone, P. & Santulli, G. From resveratrol to ISIDE11: how to activate SIRT1 and improve endothelial function? New therapeutic insights for methylenetetrahydrofolate reductase deficiency. Cell. Mol. Life Sci. 79, 451 (2022). https://doi.org/10.1007/s00018-022-04484-y
Accepted:
Published:
DOI: https://doi.org/10.1007/s00018-022-04484-y